« Back to the previous page

Also available in:

Buyer for a preclinical CRO in Europe

Company to buy

  • Size: Med-size
  • Revenue: 5-35 million EUR
  • Location of the target company: Europe 
  • Reason for acquisition: The company wants a preclinical CRO company to expand the company’s operations in Europe
  • #CFIE PHB138

Overview of this Buyer for a preclinical CRO in Europe

This buyer is a large biopharma company dedicated to the precision medicine. development. The company is interested in expanding its operations through the acquisition of a suitable CRO company in Europe.

Profile (strategy) of this Buyer for a preclinical CRO in Europe

The buyer is a large company with more than 25 years of history providing precision medicine platform. The company provides many services in different segments combining state-of-the-art medicinal chemistry, pharmacology, regulated bioanalysis and medical imaging. 

The company has operation in North America and Europe and more than 1,000 customers including big pharma companies around the world. 

The company has a presence worldwide and more than 200 employees and about 40 million EUR in revenue. 

Contact us to get details about this buyer for a preclinical CRO in Europe

Activities and products of the target 

The buyer is looking for a preclinical CRO company in Europe. An interesting company to this buyer would be a med-sized preclinical CRO company with robust portfolio of clients. The company is focusing on small molecule drug discovery to pre-IND. And also, could be interested in complementary technologies. The company should have more than 15% EBITDA margin and be profitable.

Highlights of this buyer for a liquid CDMO in Southern Europe

  • More than 25 years of history
  • Big pharma companies as clients
  • Revenue of 40 million EUR
  • Worldwide presence

Information about this buyer for a preclinical CRO in Europe

Feel free to contact us for more information regarding this Buyer for a preclinical CRO in Europe or if you know possible interested or suitable parties. For more buyers for a preclinical CRO company in Europe, please visit the section pharmaceutical companies wanted. For pharmaceutical firms for sale visit the section pharmaceutical companies for sale

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual please explain as much as possible about your personal background strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.